You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high dose Tamoxifen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Metastatic Trial in Guangzhou (Tamoxifen Oral Product)

Completed
Has Results
  • Breast Cancer Metastatic
  • Tamoxifen Oral Product
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Mar 25, 2022

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Breast Cancer Trial in London (Tamoxifen Citrate 20Mg Tab, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen Citrate 20Mg Tab
  • Placebo
  • London, England, United Kingdom
    Queen Mary University of London
Jan 13, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Stockholm (Tamoxifen 20 mg)

Active, not recruiting
  • Breast Cancer
  • +4 more
  • Tamoxifen 20 mg
  • Stockholm, Sweden
    Karolinska University Hospital
May 24, 2022

Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

Recruiting
  • Premenopausal Breast Cancer
  • Hormone Receptor-positive Breast Cancer
  • Tamoxifen Oral Product
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

Active, not recruiting
  • Breast Cancer
  • +3 more
  • citalopram hydrobromide
  • +10 more
  • Indianapolis, Indiana
  • +3 more
Feb 18, 2022

Breast Cancer Trial in Singapore (Tamoxifen)

Recruiting
  • Breast Cancer
  • Singapore, Singapore
    National Cancer Centre
Jul 5, 2021

Septic Shock Trial in Cairo (Normal saline, Methylene Blue low dose, Methylene Blue high dose)

Recruiting
  • Septic Shock
  • Normal saline
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Aug 15, 2023

Breast Cancer Trial in Milan (Tamoxifen, Placebo)

Active, not recruiting
  • Breast Cancer
  • Milan, Italy
    European Institute of Oncology
Aug 12, 2021

ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • hetrombopag 5mg po qd
  • High-dose Dexamethasone
  • (no location specified)
Jul 5, 2023

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023

Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%

Not yet recruiting
  • Liver Cirrhosis
  • Spontaneous Bacterial Peritonitis
  • 20% High Dose Albumin
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Heart Failure; With Decompensation Trial in Rochester (Bumetanide, Furosemide)

Not yet recruiting
  • Heart Failure; With Decompensation
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 7, 2023

Evaluation of High Dose Methotrexate Toxicity

Not yet recruiting
  • Methotrexate Toxicity
  • blood methotrexate level and Cystatin C level
  • (no location specified)
Nov 7, 2023

Food Allergy Trial in Warsaw (High dose OIT, Low dose OIT)

Enrolling by invitation
  • Food Allergy
  • High dose OIT
  • Low dose OIT
  • Warsaw, Poland
    Medical University of Warsaw
Jun 19, 2023

Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration Trial (High-Dose Insulin Therapy)

Not yet recruiting
  • Liver Dysfunction
  • +2 more
  • High-Dose Insulin Therapy
  • (no location specified)
Nov 6, 2023

Pulmonary Edema Trial in Alexandria (Nitroglycerin)

Enrolling by invitation
  • Pulmonary Edema
  • Alexandria, Egypt
    Alexandria University, Faculty of Medicine
Oct 25, 2023

ER+ Breast Cancer Trial in Jakarta (Tamoxifen dose adjustment)

Completed
  • ER+ Breast Cancer
  • Tamoxifen dose adjustment
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospital Semanggi
Aug 4, 2021

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Labor Long Trial in Galveston (Oxytocin)

Not yet recruiting
  • Labor Long
  • Galveston, Texas
    University of Texas Medical Branch
Mar 20, 2023

Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose

Recruiting
  • Dyslipidemias
  • Stroke, Acute Ischemic
  • combination of high-dose rosuvastatin and ezetimibe
  • high-dose rosuvastatin single administration
  • Ansan, Gyeonggi-do, Korea, Republic of
  • +2 more
May 22, 2023